On 21 September 2009, the Danish Medicines Agency decided on the future reimbursement status of medicinal products in ATC group C04 (peripheral vasodilators). Today, there is only one medicinal product of this group on the market. This medicinal product will still not be eligible for general reimbursement.
The marketing authorisation holder of the product comprised by our decision was informed in a letter dated 21 September 2009. A link to this letter (in Danish) is inserted in the factbox to the right.
Danish Medicines Agency, 24 September 2009